Evaluation of the Decision-making During Multidisciplinary Meetings for Digestive Cancers

Prospective Evaluation of the Decision-making During Multidisciplinary Meetings for Digestive Cancers

Nowadays, the recommended approach for decision-making for oncology patients is based on multidisciplinary meetings (MDT). However, the quality of decision-making during MDT depends on other factors such as the quality of presentation of clinical cases, the degree of participation of different specialists.

In this study, the investigators will evaluate the decision-making during digestive oncology MDT using the validated "Metric Of Decision-Making" tool (MDT-MODe), in the national institute of oncology (Rabat, Morocco).

Study Overview

• Status: Completed
• Conditions: Decision Making; Quality of Health Care; Patient Care Team; Neoplasms/Therapy
• Intervention / Treatment: Behavioral: response to questionnary

Detailed Description

Multidisciplinary cancer meetings are a multidisciplinary discussion and decision-making process for a patient with cancer. It allows a sharing of knowledge and decision-making, taking into account the opinion of all the specialists involved in the treatment of cancer, in order to propose the best possible decision for the patient. Nevertheless, the quality of decision-making during CPR depends on other factors such as the quality of presentation of clinical cases, the degree of participation of different specialists and the dynamics of meetings.

There are several validated tools for the quantitative assessment of the decision-making mode during CPRs. The best known is the Metric Of Decision-Making (MDT-MODe). MDT-MODe is a validated tool for the observational evaluation of teamwork and the quality of decision-making during cancer CPR.

MDT-MODe is designed to encourage teams to make holistic decisions tailored to each patient and allows an observer to assess, on a case-by-case basis, in a quantitative and objective way:

The quality of the clinical information (antecedents, radiological pathologies, pathological, comorbid, psychosocial problems and patients' points of view) Contribution to decision-making in teams of key professional groups (surgeons, physicians, oncologists, nurses, health professionals, radiologists, pathologists) Taken together, these notes provide an indication of the quality of team decision-making.

In this study, the investigators will evaluate the decision-making during digestive oncology MDT using the validated "Metric Of Decision-Making" tool (MDT-MODe), in the national institute of oncology (Rabat, Morocco).

• Study Type: Observational
• Enrollment (Actual): 200

Contacts and Locations

Study Locations

• Morocco
  • Rabat, Morocco, 10100
    • National institut of oncology

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Observations were carried out at digestive oncology multidisciplinary meetings at The National Institute of Oncology in Rabat, Morocco. The meetings are held once a week.

The study will be performed between the 23rd of May and the 4th of July 2019.

Description

Inclusion Criteria:

• All consecutive cases presented during multidisciplinary cancer meeting for digestive cancer.

Exclusion Criteria:

• Cases not registered in the electronic health record system.

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
MODE-MDT scores	The scores of the Metric Of Decision-Making tool during multidisciplinary team meeting for digestive cancer. The instrument include 10 questions rated from 1 to 5. Higher scores indicate better results. The instrument include questions about the quality of clinical information (History, radiological, pathological, comorbid health conditions, psychosocial issues, and patients' views) and the contribution to team decision making of key professional groups (Surgeons, physicians, oncologists, nurses, allied healthcare professionals, radiologists, pathologists and MDT coordinators) ans a question about the decision (Clear, deferred, no decision. Each question is analyzed separately (mean, median, standard deviation, quartiles).	60 days from the multidisciplinary team meeting

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Decision reached	The rate of cases with decisions during multidisciplinary team meetings (Clear decision about treatment in the MODE-MDT instrument).	60 days from the multidisciplinary team meeting
Decision factors	Predictive factors for reaching a clear decision about treatment during multidisciplinary team meetings. The factors analyzed are the question of the MODE-MDT instrument.	60 days from the multidisciplinary team meeting

Collaborators and Investigators

• Sponsor: Moroccan Society of Surgery

Study record dates

Study Major Dates

• Study Start (Actual): May 23, 2019
• Primary Completion (Actual): July 4, 2019
• Study Completion (Actual): September 1, 2019

Study Registration Dates

• First Submitted: June 22, 2019
• First Submitted That Met QC Criteria: June 22, 2019
• First Posted (Actual): June 27, 2019

Study Record Updates

• Last Update Posted (Actual): October 17, 2019
• Last Update Submitted That Met QC Criteria: October 15, 2019
• Last Verified: October 1, 2019

More Information

Terms related to this study

• Other Study ID Numbers: MODE_INO

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No